PTK6 has been demonstrated to enhance various aspects of tumor progression, such as cell proliferation, migration, invasion, and survival, through the modulation of several signaling pathways, including Ras/MAPK (23), PI3K/Akt/mTOR (24), and JAK-Stat (25). This evidence concerns the gene AKT1 and neoplasm.